Institute for Advanced Medical Research, Alpharetta, GA Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2016
NCT02669030
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

suvorexant (belsomra) (1 trial)

Drugs in Phase 3 Trials (2)

levomilnacipran (fetzima) (1 trial)

quetiapine (seroquel) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Depression (Phase 4)

Depressive Disorder (Phase 4)

Depressive Disorder, Major (Phase 4)

Sleep Initiation and Maintenance Disorders (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3